Skip to content

Alamar Biosciences ALMR Proceeds from maturities of short-term investments

Proceeds from maturities of short-term investments at other companies

Air Products and Chemicals logo
Air Products and ChemicalsAPD
$0-100%
Fabrinet logo
FabrinetFN
$112.11M+180%
Lyft, Inc. logo
Lyft, Inc.LYFT
$0-100%
MetLife logo
MetLifeMET
$3.69B-10.9%
Simon Property Group logo
Simon Property GroupSPG
$400M
PepsiCo logo
PepsiCoPEP
$14M

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's proceeds from maturities of short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's proceeds from maturities of short-term investments?
Alamar Biosciences (ALMR) reported proceeds from maturities of short-term investments of $18M in Q1 2025.